Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 April 2019 | Story Mamosa Makaya

Since 2016, the University of the Free State Center for Universal Access and Disability Support (CUADS) has received a grant from First National Bank worth R2 498 000, which supports tertiary bursaries for students with disabilities. Bursary holders are funded through CUADS, as the administrator of the bursaries.
  
These are students enrolled for various academic programmes who require academic assistance and/or assistive devices such as electronic handheld magnifiers, laptops, and hearing aids. The FNB grant also covers tuition, accommodation, study material and books, and meals.  The success of the grant is already evident, with one of the recipients having graduated with a Bachelor of Arts degree in December 2018. A second student was capped at the April 2019 graduations with a BSc Honours in Quantity Surveying.
 
Supporting the principles of the ITP

The UFS received the grant from FNB in instalments, starting in the 2016 academic year to date, supporting the needs of 40 disabled students. This grant and the work of CUADS speaks to and supports the principles of the Integrated Transformation Plan (ITP), namely inclusivity, transformation, and diversity. The vision of the Universal Access work stream is to enable the UFS to create an environment where students with disabilities can experience all aspects of student life equal to their non-disabled peers. The ITP provides for the recognition of the rights of people with disabilities as an important lesson in social justice and an opportunity to reinforce university values.

The successful administration of the grant to benefit past and present students is a ‘feather in the cap’ of CUADS, and is a shining example of the impact of public private investment and the endless possibilities that open up when there is a commitment to developing future leaders in academic spaces, allowing them to thrive by creating a learning environment that is welcoming and empowering. 



News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept